Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, July 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

patent: 4 patents

Citations

dimensions_citation: 96 Dimensions

Readers on

mendeley: 33 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

METHOD FOR PREDICTING RISK OF HYPERTENSION ASSOCIATED WITH ANTI-ANGIOGENESIS THERAPY

Application EP-3085793-A1

European Patent Office

Method for predicting risk of hypertension associated with anti-angiogenesis therapy

Application CN-103946395-A

China

METHOD OF TREATING CANCER

Application WO-2013113796-A1

World Intellectual Property Organisation (WIPO)

METHOD FOR PREDICTING RISK OF HYPERTENSION ASSOCIATED WITH ANTI-ANGIOGENESIS THERAPY

Application WO-2013030168-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.